These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

104 related articles for article (PubMed ID: 18307244)

  • 1. Relevance of COX-2 gene expression in dementia with lewy bodies associated with Alzheimer pathology.
    Saldaña M; Pujols L; ; Roca-Ferrer J; Cardozo A; Aguilar E; Bonastre M; Marin C
    Mov Disord; 2008 Apr; 23(6):804-10. PubMed ID: 18307244
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Nuclear factor kappa-B p50 and p65 subunits expression in dementia with Lewy bodies.
    Saldaña M; Mullol J; Aguilar E; Bonastre M; Marin C
    Neuropathol Appl Neurobiol; 2007 Jun; 33(3):308-16. PubMed ID: 17442064
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The medial temporal lobe in dementia with Lewy bodies: a comparative study with Alzheimer's disease.
    Lippa CF; Johnson R; Smith TW
    Ann Neurol; 1998 Jan; 43(1):102-6. PubMed ID: 9450774
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Amyloid-beta deposition in the cerebral cortex in Dementia with Lewy bodies is accompanied by a relative increase in AbetaPP mRNA isoforms containing the Kunitz protease inhibitor.
    Barrachina M; Dalfó E; Puig B; Vidal N; Freixes M; Castaño E; Ferrer I
    Neurochem Int; 2005 Feb; 46(3):253-60. PubMed ID: 15670642
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Dementia with Lewy bodies and Parkinson's disease with dementia: are they different?
    Tsuboi Y; Dickson DW
    Parkinsonism Relat Disord; 2005 Jun; 11 Suppl 1():S47-51. PubMed ID: 15885629
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Impaired metabotropic glutamate receptor/phospholipase C signaling pathway in the cerebral cortex in Alzheimer's disease and dementia with Lewy bodies correlates with stage of Alzheimer's-disease-related changes.
    Albasanz JL; Dalfó E; Ferrer I; Martín M
    Neurobiol Dis; 2005 Dec; 20(3):685-93. PubMed ID: 15949941
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The pathology of the substantia nigra in Alzheimer disease with extrapyramidal signs.
    Burns JM; Galvin JE; Roe CM; Morris JC; McKeel DW
    Neurology; 2005 Apr; 64(8):1397-403. PubMed ID: 15851730
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Reappraisal of a consecutive autopsy series of patients with primary degenerative dementia: Lewy-related pathology.
    Oinas M; Sulkava R; Polvikoski T; Kalimo H; Paetau A
    APMIS; 2007 Jul; 115(7):820-7. PubMed ID: 17614849
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Low alpha-synuclein 126 mRNA levels in dementia with Lewy bodies and Alzheimer disease.
    Beyer K; Humbert J; Ferrer A; Lao JI; Carrato C; López D; Ferrer I; Ariza A
    Neuroreport; 2006 Aug; 17(12):1327-30. PubMed ID: 16951579
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A critical reappraisal of current staging of Lewy-related pathology in human brain.
    Jellinger KA
    Acta Neuropathol; 2008 Jul; 116(1):1-16. PubMed ID: 18592254
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prevalence and impact of vascular and Alzheimer pathologies in Lewy body disease.
    Jellinger KA; Attems J
    Acta Neuropathol; 2008 Apr; 115(4):427-36. PubMed ID: 18273624
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Differential expression of alpha-synuclein isoforms in dementia with Lewy bodies.
    Beyer K; Lao JI; Carrato C; Mate JL; López D; Ferrer I; Ariza A
    Neuropathol Appl Neurobiol; 2004 Dec; 30(6):601-7. PubMed ID: 15541000
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Differential nigral expression of bcl-2 protein family in the pure and common forms of Dementia with Lewy bodies: relevance for dopaminergic neuronal vulnerability.
    Saldaña M; Aguilar E; Bonastre M; Marin C
    J Neural Transm (Vienna); 2007; 114(11):1469-77. PubMed ID: 17641817
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Reduced ubiquitin C-terminal hydrolase-1 expression levels in dementia with Lewy bodies.
    Barrachina M; Castaño E; Dalfó E; Maes T; Buesa C; Ferrer I
    Neurobiol Dis; 2006 May; 22(2):265-73. PubMed ID: 16380264
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Histopathology of the substantia nigra in Alzheimer's disease.
    Reyes MG; Faraldi F; Chandran R; Verano A; Levi AC
    Panminerva Med; 1996 Mar; 38(1):8-14. PubMed ID: 8766873
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Abnormal levels of prohibitin and ATP synthase in the substantia nigra and frontal cortex in Parkinson's disease.
    Ferrer I; Perez E; Dalfó E; Barrachina M
    Neurosci Lett; 2007 Mar; 415(3):205-9. PubMed ID: 17284347
    [TBL] [Abstract][Full Text] [Related]  

  • 17. In dementia with Lewy bodies, Braak stage determines phenotype, not Lewy body distribution.
    Weisman D; Cho M; Taylor C; Adame A; Thal LJ; Hansen LA
    Neurology; 2007 Jul; 69(4):356-9. PubMed ID: 17646627
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Neuropathology of Parkinson's disease dementia and dementia with Lewy bodies with reference to striatal pathology.
    Tsuboi Y; Uchikado H; Dickson DW
    Parkinsonism Relat Disord; 2007; 13 Suppl 3():S221-4. PubMed ID: 18267239
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Upregulation of amyloid precursor protein isoforms containing Kunitz protease inhibitor in dementia with Lewy bodies.
    Beyer K; Lao JI; Carrato C; Mate JL; López D; Ferrer I; Ariza A
    Brain Res Mol Brain Res; 2004 Nov; 131(1-2):131-5. PubMed ID: 15530662
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Frontotemporal lobar degeneration and dementia with Lewy bodies: clinicopathological issues associated with antemortem diagnosis.
    Yokota O
    Psychogeriatrics; 2009 Jun; 9(2):91-102. PubMed ID: 19604332
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.